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Abstract
Background: The joint distribution of asthma and chronic obstructive pulmonary disease (COPD) has not been well
described. This study aims at determining the prevalence of self-reported physician diagnoses of asthma, COPD and of the
asthma-COPD overlap syndrome and to assess whether these conditions share a common set of risk factors.
Methods: A screening questionnaire on respiratory symptoms, diagnoses and risk factors was administered by mail or
phone to random samples of the general Italian population aged 20–44 (n = 5163) 45–64 (n = 2167) and 65–84 (n = 1030) in
the frame of the multicentre Gene Environment Interactions in Respiratory Diseases (GEIRD) study.
Results: A physician diagnosis of asthma or COPD (emphysema/chronic bronchitis/COPD) was reported by 13% and 21% of
subjects aged ,65 and 65–84 years respectively. Aging was associated with a marked decrease in the prevalence of
diagnosed asthma (from 8.2% to 1.6%) and with a marked increase in the prevalence of diagnosed COPD (from 3.3% to
13.3%). The prevalence of the overlap of asthma and COPD was 1.6% (1.3%–2.0%), 2.1% (1.5%–2.8%) and 4.5% (3.2%–5.9%)
in the 20–44, 45–64 and 65–84 age groups. Subjects with both asthma and COPD diagnoses were more likely to have
respiratory symptoms, physical impairment, and to report hospital admissions compared to asthma or COPD alone
(p,0.01). Age, sex, education and smoking showed different and sometimes opposite associations with the three
conditions.
Conclusion: Asthma and COPD are common in the general population, and they coexist in a substantial proportion of
subjects. The asthma-COPD overlap syndrome represents an important clinical phenotype that deserves more medical
attention and further research.
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Introduction
Asthma and chronic obstructive pulmonary disease (COPD) are
a major public health problem because of their high and still rising
prevalence, their associated morbidity, mortality and socio-
economic costs [1–4].
Although asthma and COPD are different diseases, differential
diagnosis is sometimes difficult and may be impossible in some
older patients. [5] Furthermore, asthma and COPD may coexist:
more than 40% of patients with COPD report a history of asthma,
[6] and asthma has been recognized to be a risk factor for
developing COPD. [7] Patients who have both COPD and asthma
(overlap syndrome) have a more rapid disease progression, [8] a
worse health-related quality of life, more frequent respiratory
exacerbations, [9] increased co-morbidities and health care
utilization than those with either disease alone [10–11].
The joint epidemiological distribution of asthma and COPD in
the general population has not been thoroughly described. One
reason is that the presence of the overlap syndrome is often an
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exclusion criterion in studies investigating either disease alone.
[9,12] Another reason is that studies on asthma are usually
performed in populations of children or young adults, [13–14]
where the prevalence of COPD is negligible, while studies on
COPD are usually performed in elderly populations where the
prevalence of asthma is low [15].
Assessing self-reported -physician-diagnosed -COPD and asth-
ma in large representative samples of the general population is one
of the simplest and most affordable methods to estimate the
prevalence of these diseases. [16] Although the physician diagnosis
has been questioned because of the potential inaccuracy, [17]
recent studies showed that it has considerably improved during the
last decade, probably due to increased lung function testing and
dissemination of guidelines [18].
In this study we aimed at:
N determining the prevalence of the self-reported physician -
diagnoses of asthma, COPD and of the asthma-COPD overlap
syndrome in representative samples of young, middle-aged and
elderly subjects from the general population in Italy;
N assessing whether subjects with asthma, COPD and the
overlap syndrome diagnoses share common risk factors, and
whether these vary with age.
For these purposes the data from the Gene Environment
Interaction in Respiratory Diseases (GEIRD) study were used.
Methods
Study Design
GEIRD is a two-stage multicentre study started in 2007. [19] As
a part of GEIRD stage 1, samples of about 3000 subjects aged 20–
44 years (male : female = 1:1) were randomly selected from the
registry of the local health authority in four Italian centres: Turin,
Pavia, Verona and Sassari. Additional random samples of about
1000 subjects aged 45–64 and 65–84 years were selected in 4 and
in 2 centres respectively by the same procedure (table 1). All the
eligible subjects were administered a postal screening question-
naire up to three times in the case of non response. A final phone
interview was carried out to reach the remaining non responders.
Institutional Board Ethic Committee
Ethical approval was obtained in each centre from the
appropriate institutional review board (Turin: Azienda Sanitaria
Locale TO-2; Pavia: ‘‘Istituto Ricovero e Cura a Carattere
Scientifico’’, Policlinico San Matteo; Verona: ‘‘Istituti Ospedalieri
di Verona’’; Sassari: ‘‘Azienda Ospedaliera Universitaria di
Sassari’’). All the participants were fully informed about all the
aspects of the research project and consented to complete and
return the questionnaire.
Screening Questionnaire, Respiratory Outcomes and
Potential Confounders
The GEIRD Screening Questionnaire (available on www.geird.
org) is a modified version of questionnaires used in previous
international and national studies. [20]. It is aimed at investigating
the presence of symptoms of asthma, allergic rhinitis, chronic
bronchitis/COPD and dyspnoea, and some environmental
exposures. Questions on doctor diagnosis of asthma and COPD
were also included.
Based on the answers to the questionnaire, a subject was
considered to have a physician diagnosis of:
N asthma if s/he answered affirmatively to both questions ‘‘Have
you ever had asthma?’’ and ‘‘Was this confirmed by a
doctor?’’;
N COPD if s/he gave a positive answer to the question: ‘‘Have
you ever been told by a doctor that you have or had chronic
bronchitis, chronic obstructive pulmonary disease (COPD) or
emphysema?’’.
The self reported physician diagnosis of COPD relied on the
knowledge of the terms COPD, chronic bronchitis and emphy-
sema. These are the most widely used terms when Italian doctors
give patients a diagnosis of COPD.
The questionnaire also collected information on the presence of
the following respiratory symptoms/conditions: wheezing or
whistling in the chest in the last 12 months, asthma attacks in
the last 12 months, current use of medicines for asthma, allergic
rhinitis, chronic bronchitis (cough or phlegm on most days for a
minimum of 3 months a year for at least 2 successive years). The
dyspnoea scale of Medical Research Council (MRC) was used as a
measure of the functional limitation due to breathlessness (grade
$3: ‘‘do you get short of breath walking with other people of your
own age on level ground, or do you have to stop for short of breath
when walking at own pace on level ground?’’) [21].
Gender, age, season when the questionnaire was filled in, type
of contact (postal waves and telephone interview) were considered
as potential confounders. Moreover, as the centres had different
final response rates, the centre-specific cumulative response
percentile rank to which subjects had answered was included in
the analysis. [3] The following potential risk factors for respiratory
symptoms were also included: smoking habits (current smoker,
lifetime non-smoker and ex-smoker, defined as at least 1-year since
quit), educational level (compulsory, high school, college/univer-
sity education), the presence of industrial plants near home, self-
reported heavy traffic near home (occasional/none, frequent,
constant).
Statistical Analysis
Categorical data were summarized as counts with percentages.
Comparisons of variables across strata were performed by the
Pearson Chi-squared test.
Age-sex adjusted prevalence rates of physician-diagnosed
asthma and/or COPD were obtained through a logistic regression
model with a dummy indicator of diagnosed asthma and/or
COPD as dependent variables and centre, percentile rank of
cumulative response, type of contact and season as covariates.
To study the joint distribution of asthma and COPD, a four-
level indicator was obtained (0: neither asthma nor COPD; 1:
asthma only; 2: asthma and COPD; 3: COPD only). The
association of the previous conditions with potential risk factors
Table 1. Number of responders (response rate %) by age-
class in the four centres participating in the GEIRD stage 1
(screening questionnaire).
Centre Age class (years)
[20–44] [45–64] [65–84]
Verona 1746 (67.7%) 676 (70.1%) 591 (60.1%)
Pavia 966 (37.1%) 460 (54.9%)
Torino 1206 (54.7%) 502 (60.2%)
Sassari 1245 (53.0%) 529 (62.8%) 439 (44.3%)
Overall 5163 (53.0%) 2167 (62.3%) 1030 (52.2%)
doi:10.1371/journal.pone.0062985.t001
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was studied by fitting a multinomial regression model to the data,
using the four-level indicator as the dependent variable, the other
potential confounders and risk factors as independent variables.
The interaction of age with other independent variables in
determining the joint distribution of physician diagnoses of asthma
and COPD was tested by likelihood-ratio test including in the
regression model an appropriate interaction term.
Statistical analyses were performed with STATA 12.1 (Stata
Corp LP, College Station, TX, USA).
Results
Response Rates and Sample Characteristics
The response rate (table 1) was minimum in the elderly (52.2%)
and maximum in people aged 45–64 (62.3%). The distribution of
sex and smoking habits showed a statistically significant variation
(p,0.001) across age groups. The percentage of women was
53.6%, 52.2% and 42.7% in the 20–44, 45–64 and 65–84 yrs age
groups, respectively. In these age groups, 26.6%, 23.4% and 9.6%
of the subjects were current smokers, while 55.4%, 42.2% and
53.0% of the subjects never smoked.
Prevalence of Self Reported Doctor Diagnosed Asthma
and COPD
The percentage of subjects with either the doctor diagnosis of
asthma or COPD (figure 1) was almost constant up to 65 years of
age: 13.1% (95%CI: 12.2%–14%) and 12.7% (95%CI: 11.3%–
14.2%) in the 20–44 and 45–64 age classes respectively, and it
increased to 20.7% (95%CI: 18.1%–23.3%) in the 65–84 age
group, being similar in men and women.
The prevalence of the diagnosis of asthma alone almost halved
(from 8.2% to 2.9%), while that of COPD alone almost doubled
(from 3.3% to 13.3%) every twenty years of age (table 2 and
figure 1). The prevalence of asthma-COPD overlap syndrome
significantly increased with age (p,0.001): it was 1.6%, 2.1% and
4.5% in the 20–44, 45–64 and 65–84 age groups, respectively.
Among subjects who reported physician-diagnosed asthma, the
percentage of the asthma-COPD overlap syndrome was 16%,
30% and 61% in the 20–44, 45–64 and 65–84 age groups,
respectively. Conversely, among subjects who reported COPD the
percentage of the asthma-COPD overlap syndrome was 33%,
27% and 25% in the three age group, respectively.
Distribution of Symptoms, Physical Limitation and
Hospitalization According to the Diagnoses of Asthma
and COPD
Respiratory symptoms, physical limitation (MRC$3) and
hospitalization were statistically significantly increased in subjects
with either doctor diagnosed asthma or COPD or both (p,0.001)
The risk of having respiratory symptoms or using medicines
ranged from a minimum of 5-fold (wheezing) to a maximum of
200-fold (current use of anti-asthmatic drugs) with respect to
subjects without a doctor diagnosis (table 3). Subjects reporting
the diagnosis of the asthma-COPD overlap syndrome had the
highest prevalence of all the respiratory symptoms/conditions
considered, with the exception of allergic rhinitis and they differed
significantly from the subjects with the diagnosis of asthma or
COPD alone (see the non overlapping of confidence intervals in
table 4) for the majority of symptoms investigated.
Factors Associated with the Diagnosis of Asthma and
COPD
Women were more likely to have the asthma-COPD overlap
syndrome compared to men (RR = 1.63; 95%CI: 1.15–2.31). The
risk of reporting a diagnosis of asthma only was significantly higher
in young (p = 0.001) and highly educated people (p = .002), while
the opposite held true for COPD, with or without asthma (table 4)
(p,.001).
Smoking was significantly associated with both asthma and
COPD. Ex-smokers were at a lower risk compared to current
smokers, but they had a significantly higher risk of COPD
(RR = 1.56; 95%CI:1.16–2.08) and of the COPD-asthma overlap
syndrome (RR = 1.56; 95%CI: 1.04–2.35) with respect to non-
smokers. Higher levels of heavy traffic near home were signifi-
cantly associated with a greater risk of having diagnosed COPD.
Age did not modify the associations of these risk factors with the
diagnoses of asthma, COPD or both.
Discussion
The main findings of this analysis are:
N About 1 out of 8 subjects ,65 yrs old and 1 out of 5 subjects
aged 65 or more yrs reported a physician diagnosis of asthma
or COPD. Aging was associated with a marked decrease in the
prevalence of asthma and with a marked increase in the
prevalence of COPD. However, the percentage of subjects
reporting either diagnosed asthma or COPD or both was
almost constant until 65 years of age;
Figure 1. Prevalence* of self-reported physician-diagnosed
asthma and/or COPD in the Italian population. *Adjusted for
season, cumulative percentile rank of response, type of survey (postal
waves/telephone) and centre.
doi:10.1371/journal.pone.0062985.g001









[20–44] 8.2 (7.5–9) 1.6 (1.3–2) 3.3 (2.8–3.8)
[45–64] 4.9 (4–5.9) 2.1 (1.5–2.8) 5.7 (4.7–6.7)
[65–84] 2.9 (1.8–4) 4.5 (3.2–5.9) 13.3 (11.1–15.5)
Prevalence (%) with 95% confidence interval (CI).
doi:10.1371/journal.pone.0062985.t002
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N The prevalence of the self-reported physician-diagnosed
asthma-COPD ‘‘overlap syndrome’’ in Italy ranged from
1.6% in the 20–44 age class to 4.5% in the 65–84 age class.
Subjects with the overlap syndrome had a statistically
significantly higher frequency of respiratory symptoms,
functional limitation and hospitalization with respect to
subjects with the diagnosis of asthma or COPD alone;
N Age, sex, education and active smoking showed different and
sometimes opposite associations with asthma, COPD and the
overlap syndrome. Age did not modify the associations of the
previous factors with respiratory diseases.
Prevalence of Asthma and COPD in the General
Population Aged 20–85 Years
There is a paucity of knowledge on the prevalence of asthma in
the elderly, [22] probably because asthma and COPD tend to
overlap, making the diagnosis complex. [23,24] On the contrary,
the large majority of epidemiological studies on COPD, which is
usually assumed to be an ‘‘aging disease’’, has been focused on
elderly population and only few studies have been performed on
young adult populations [25].
Our study is one of the few that reports the prevalence of both
diseases in people aged from 20 to 84 years. It documents that
asthma and COPD are major health problems, affecting about
13% of adults and 20% of the elderly. As people got older, the
prevalence of asthma decreased (from 8.2% to 2.9%), while the
prevalence COPD increased (from 3.3% to 13.3%). However, the
prevalence of asthma and COPD remained non negligible even at
the extremes of the age range. It is likely that this age-related
pattern of asthma and COPD reflects both the true pattern of
disease prevalence and the differential doctor’s diagnostic
propensity according to the age of their patients (diagnostic bias).
[23] Indeed, distinguishing between asthma and COPD can be
quite challenging, even for the most expert medical professional,
and COPD is often misdiagnosed as asthma in young people,




no asthma, no COPD
%(95%CI) asthma only %(95%CI)
asthma+COPD overlap
%(95%CI) COPD only %(95%CI)
Wheezing 9.9 (9.2–10.6) 43.4 (39.2–47.7) 78.7 (71.3–84.5) 42.7 (37.6–47.9)
Asthma attacks 0.7 (0.5–0.9) 38.8 (34.6–43.2) 56.9 (48.7–64.8) 4.4 (2.7–6.9)
Antiasthmatic drugs 0.3 (0.2–0.4) 29.8 (25.8–34) 55.4 (47–63.5) 2 (1.1–3.8)
Allergic rhinitis 18.2 (17.3–19.1) 59.2 (54.9–63.4) 53.5 (45.5–61.3) 23.9 (19.7–28.6)
Cough or phlegm 10.2 (9.5–10.9) 23.1 (19.6–26.9) 61.7 (53.7–69.1) 54 (48.7–59.2)
MRC{ $3 3.8 (3.3–4.3) 9.3 (7.1–12.2) 38.8 (31.1–47.1) 20.8 (17–25.2)
Hospitalizations 0.4 (0.2–0.5) 1.1 (0.5–2.4) 3.1 (1.4–6.7) 2.5 (1.4–4.5)
*Adjusted for gender, age (class), season, % of answers to the questionnaire, type of survey (postal/telephone), and centre.
{MRC: Medical Research Council dyspnea score.
doi:10.1371/journal.pone.0062985.t003
Table 4. Factors associated with the diagnoses of asthma, COPD, and the asthma–COPD overlap syndrome.
Asthma only Asthma+COPD COPD only
Gender males 1 1 1
females 0.87 (0.72–1.04) 1.63 (1.15–2.31) 1.15 (0.92–1.44)
Age [20–44] 1 1 1
[45–64] 0.60 (0.47–0.77) 1.12 (0.75–1.69) 1.57 (1.20–2.07)
[65–85] 0.48 (0.3–0.77) 1.43 (0.76–2.70) 5.50 (3.75–8.08)
Smoking habits non-smoker 1 1 1
current smoker 1.27 (1.02–1.58) 1.70 (1.12–2.60) 3.16 (2.41–4.16)
ex smoker 0.99 (0.78–1.26) 1.56 (1.04–2.35) 1.56 (1.16–2.08)
Education compulsory 1 1 1
high school 1.26 (0.99–1.6) 0.45 (0.31–0.65) 0.70 (0.55–0.90)
college/university 1.61 (1.24–2.09) 0.30 (0.17–0.51) 0.38 (0.26–0.57)
Industries nearby 1.00 (0.78–1.27) 0.91 (0.55–1.50) 1.30 (0.98–1.73)
Heavy traffic occasional/none 1 1 1
frequent 1.00 (0.78–1.27) 0.91 (0.55–1.50) 1.30 (0.98–1.73)
constant 1.38 (1.07–1.77) 1.57 (0.98–2.50) 1.67 (1.24–2.24)
Relative Risk Ratios* (RRR) with 95%CI, with subjects without diagnosed diseases as reference group. Statistically significant associations are shown in bold.
*adjusted for all variables presented in this table plus design confounders (season, cumulative percentile rank of response, type of interview, GEIRD centre).
doi:10.1371/journal.pone.0062985.t004
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while the opposite happens in the elderly. [26] This could explain
in part our finding showing that the prevalence of asthma and/or
COPD is invariant in the 20–65 age range.
Our estimates of the prevalence of asthma in Italy based on the
self-reported doctor diagnosis are in line with those recently
obtained on adult representative national samples, by using both
an internationally validated questionnaire and the diagnosis of
asthma made by Italian General Practitioners. [3,27] The
agreement between prevalence estimates from health interview
surveys and those from GP registration may indicate an
improvement in the ability of general practitioners to diagnose
asthma during the last decade, which is probably due to the
increased diffusion of spirometry and dissemination of asthma
guidelines [18].
At variance, the prevalence estimates of COPD may change
considerably according to the diagnostic tools used. In general,
epidemiological studies based on physician diagnoses reported
lower prevalence estimates than those relying on spirometry,
[15,28] which is the gold standard definition for COPD (GOLD
guidelines). [2] As a consequence of the definition of COPD
used in our study, a certain degree of misclassification probably
occurred: some subjects with spirometrically-defined COPD
might not have had a doctor diagnosis, and a non-negligible
percentage of subjects who reported a physician-diagnosis might
not have met the spirometric criteria. [29] Despite its limitation,
the physician-diagnosed COPD continues to be widely used in
epidemiological surveys on large representative national samples,
[16,30] either because of its simplicity and cost saving, and
because it gives us a ‘‘real life’’ picture of the percentage of
people in a country that are diagnosed and treated as COPD
patients by doctors. Our estimates of the prevalence of
physician-diagnosed COPD in Italy are in the range of those
reported in other countries [24,31].
Prevalence of the Asthma-COPD Overlap Syndrome in
the General Population
It is well known that some patients suffer from both asthma
and COPD, and that they represent an important clinical
population with peculiar characteristics. [6,29] In fact, it has
been frequently observed that some patients with asthma have
an accelerated decline in lung function, especially if they are
smokers, [8,32] and that some patients with COPD have a
good response to treatment with bronchodilators and ICS. It is
still an open question whether the overlap syndrome represents
the coexistence of two distinct airway diseases or whether there
are common underlying pathogenic mechanisms leading to this
phenotype. [33] In comparison to previous studies that have
considered selected groups of patients, such as COPD patients,
[11,34] our study enabled us to assess the prevalence of the
asthma-COPD overlap syndrome in the general population. We
found that this prevalence ranged from a minimum of 1.6%
(95%CI: 1.3%–2.0%) in the 20–44 age group to 4.5% (95%CI:
3.2%–5.9) in the 60–84 age group.
These data point out that the asthma-COPD overlap syndrome
affects many subjects and becomes more prevalent with advancing
age. Furthermore, in agreement with previous studies, [9–11] we
found that patients with the overlap syndrome were more likely to
have respiratory symptoms, physical impairment and to report
hospital admission for respiratory diseases compared to subjects
with asthma or COPD alone. In summary, our findings clearly
illustrate that there are many reasons to focus medical attention
and increase the research efforts on asthma-COPD overlap
syndrome patients.
Risk Factors of Asthma, COPD and of the Overlap
Syndrome
Asthma-COPD overlap syndrome can develop when there is an
accelerated decline in lung function, or incomplete lung growth, or
both. [23,24] The determinants for these events, like tobacco
smoke exposure etc., are presumed to be shared with asthma and
COPD. [32,35] However, the distribution of risk factors across
asthma, COPD and the overlap syndrome has not been
thoroughly investigated and may offer new insights into the
mechanisms of the different respiratory diseases.
Our findings show that the risk factor profiles of subjects with
the diagnosis of asthma, COPD and asthma-COPD overlap
syndrome are different, even if they share some common patterns.
Women had a higher susceptibility for the asthma-COPD overlap
syndrome (OR:1.63; 95%CI: 1.15–2.31) than men, while gender
was not associated with either the prevalence of asthma or COPD
alone. Accordingly, the higher prevalence of adult asthma
reported in women could be at least partially due to their
increased susceptibility to the overlap syndrome [36].
In agreement with a previous practice-based study performed
by the Italian College of General Practitioners, [27] age was
strongly and negatively associated with the prevalence of asthma
alone, while the opposite occurred for the prevalence of COPD
alone. The prevalence of the overlap syndrome showed only a
weak positive association with aging, after adjusting for the other
potential confounders. Considering that the incidence of asthma
has been constantly on the increase during the last century, the
negative association of the prevalence of asthma with age might be
due, at least in part, to a ‘‘generational’’ effect [3] as well as to the
doctors’ diagnostic propensity.
Although it is recognised that active and passive smoking are the
major risk factors for COPD, [2] there are conflicting results on
the association between asthma and smoking. [37] In our study,
smoking was significantly and positively associated with all the
three diseases, however the strength of the association was much
higher for COPD than for asthma or the overlap syndrome.
Differently from some studies, [38] and in agreement with
others, [39] we found that more educated people had significantly
higher prevalence rates of asthma. Apparently contradictory
evidence regarding the relationship between social class and
asthma could be related to differences in the in the geographical
area studied or in the definition of asthma. [40].
In agreement with a large body of epidemiological evidence, [2]
our data show that the prevalence of COPD is significantly lower
in more educated people. A similar association was found for the
asthma-COPD overlap syndrome. The presence of the overlap
syndrome among asthmatics could therefore explain why other
studies found an inverse association between asthma and
education.
As previously reported, [41] we found a clear and statistically
significant association between self-reported exposure to traffic air
pollution and the prevalence of COPD. The prevalence of asthma
and of the asthma-COPD overlap syndrome was definitely less
influenced by the exposure to air pollution.
In summary, the heterogeneity of the associations of the studied
risk factors across the different respiratory diseases shown in our
analysis seems to suggest that asthma, COPD and the asthma-
COPD overlap syndrome could represent different phenotypes.
Limits of the Study
To our knowledge, this study provides the first large scale
estimate of the joint distribution of asthma and COPD in general
population. It has a number of limitations. Firstly, it was not
possible to assess if and how asthma and COPD interact in the
Asthma-COPD Overlap in the General Population
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pathogenesis of the overlap-syndrome and which of the two
occurred first, because of the cross-sectional design of the study.
Then, our definitions of asthma and COPD were based on self-
reported physician-diagnoses of the disease, and did not rely on
lung function tests. As such, there might be an issue of recall bias.
However, these definitions have been widely used in large
international surveys, [13–14] and have proved to be reasonably
reliable. [15] Our definition of COPD was based on the physician
diagnosis of at least one of three conditions (COPD, emphysema
and chronic bronchitis), and this might have resulted in an
overestimation of the actual prevalence of COPD. This definition
was used because, for the sake of simplicity, Italian GPs often use
the terms ‘‘emphysema’’ and ‘‘chronic bronchitis’’ when giving a
COPD diagnosis to their patients. Furthermore it is also likely that
our definition of diseases based on the doctor diagnoses could have
led to an underdiagnosis of a certain proportion of the population,
as suggested by the fact that about 10% and 1% of the subjects
without a diagnosis of asthma or COPD reported wheezing and
asthma attacks in the last year respectively. Furthermore the
relatively low number of elderly subjects included in our study
(subjects aged 65 yrs or more were recruited in only 2 out of 4
centers) and the predominant white European population of Italy
may partially limit the generalizability of our results.
The overall response rate was quite good with an average of
over 50% in all age groups. The main outlier was the centre of
Pavia, with a significantly lower response rate in the 20–44 age
group. However, the distribution of asthma and COPD in the
centre of Pavia was similar to those obtained in the other centers
(data not reported), suggesting that the low response rate in this
centre did not bias our results.
Conclusion
Asthma and COPD affect more than one out of eight of adults
aged 20 years or older. The coexistence of both diseases is present
in a substantial proportion of subjects and increases with
advancing age. Subjects with the asthma-COPD overlap syn-
drome seem to be a specific phenotype that has more respiratory
symptoms, more physical impairment, consume more medical
resources and have a peculiar pattern of risk factors compared to
asthma or COPD alone. Improvements in monitoring, in the
treatment and in the research on the asthma-COPD overlap
syndrome are necessary.
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